Fig. 2.

Repertoire of somatic mutations in metaplastic breast carcinomas and uterine carcinosarcomas. (A) Total number of somatic mutations and nonsynonymous somatic mutations per Mb in metaplastic breast cancers (MBCs) reanalyzed from Ng et al. [2] and uterine carcinosarcomas (UCSs) reanalyzed from The Cancer Genome Atlas (TCGA) [19]. Mann–Whitney U‐test employed. (B) Nonsynonymous somatic mutations identified in WES data from MBCs reanalyzed from Ng et al. [2], left, and UCSs reanalyzed from TCGA [19], right. Cases are shown in columns and genes in rows. Mutation types, mutational signatures, LSTs, NtAIs, small deletion length, small insertion and deletion (indel) microhomology, and clinicopathologic factors are color‐coded according to the legend. . (C) Fraction of the genome altered in MBCs reanalyzed from Ng et al. [2] and UCSs reanalyzed from TCGA [19]. Mann–Whitney U‐test employed.